Literature DB >> 6508266

Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.

R H Glew, R A Pavuk.   

Abstract

An in vitro comparison of the early synergistic interaction between amikacin and each of six beta-lactam antibiotics was made by using time-kill curves against 48 multiply resistant members of the family Enterobacteriaceae. Overall, these six combinations demonstrated early synergism (greater than or equal to 2 logs of increased kill after 7 h of incubation) against the 48 strains on 74% (range, 67 to 85%) of occasions; cefotaxime-amikacin and piperacillin-amikacin were the most efficacious combinations. Antagonism was not observed with any of the combinations against any of the 48 Enterobacteriaceae strains tested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508266      PMCID: PMC176174          DOI: 10.1128/AAC.26.3.378

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Clinical significance of in vitro synergism between antibiotics in gram-negative infections.

Authors:  J Klastersky; R Cappel; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

2.  Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other beta-lactam antibiotics.

Authors:  M N Gwynn; T L Webb; G N Rolinson
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

3.  In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.

Authors:  M T Kelly; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

4.  Antibiotic synergy and antagonism against clinical isolates of Klebsiella species.

Authors:  R M D'Alessandri; D J McNeely; R M Kluge
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

5.  Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.

Authors:  T B Tjandramaga; A Mullie; R Verbesselt; P J De Schepper; L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

6.  In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.

Authors:  J H Jorgensen; S A Crawford; G A Alexander
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

7.  Antimicrobial synergism in the therapy of gram-negative rod bacteremia.

Authors:  E T Anderson; L S Young; W L Hewitt
Journal:  Chemotherapy       Date:  1978       Impact factor: 2.544

8.  Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.

Authors:  T O Kurtz; D J Winston; D A Bruckner; W J Martin
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

9.  Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.

Authors:  S M Markowitz; D J Sibilla
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

10.  Studies on gonococcus infection. XI. Comparison of in vivo and vitro association of Neisseria gonorrhoeae with human neutrophils.

Authors:  G King; J F James; J Swanson
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

View more
  5 in total

1.  In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.

Authors:  M D Lyon; K R Smith; M S Saag; G A Cloud; C G Cobbs
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Activity of cefotiam in combination with beta-lactam antibiotics on enterobacterial hospital strains.

Authors:  R Vanhoof; J M Hubrechts; H J Nyssen; E Nulens; J Leger; N de Schepper; E Kupperberg; M L Couvreur
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

Review 3.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  Early effects of beta-lactams on aminoglycoside uptake, bactericidal rates, and turbidimetrically measured growth inhibition in Pseudomonas aeruginosa.

Authors:  M H Miller; S A Feinstein; R T Chow
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

5.  Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa.

Authors:  D M Cappelletty; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.